147 related articles for article (PubMed ID: 24093105)
1. A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo.
Arribillaga L; Durantez M; Lozano T; Rudilla F; Rehberger F; Casares N; Villanueva L; Martinez M; Gorraiz M; Borrás-Cuesta F; Sarobe P; Prieto J; Lasarte JJ
Biomed Res Int; 2013; 2013():864720. PubMed ID: 24093105
[TBL] [Abstract][Full Text] [Related]
2. The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo.
Lasarte JJ; Casares N; Gorraiz M; Hervás-Stubbs S; Arribillaga L; Mansilla C; Durantez M; Llopiz D; Sarobe P; Borrás-Cuesta F; Prieto J; Leclerc C
J Immunol; 2007 Jan; 178(2):748-56. PubMed ID: 17202335
[TBL] [Abstract][Full Text] [Related]
3. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
Mansilla C; Gorraiz M; Martinez M; Casares N; Arribillaga L; Rudilla F; Echeverria I; Riezu-Boj JI; Sarobe P; Borrás-Cuesta F; Prieto J; Lasarte JJ
J Hepatol; 2009 Sep; 51(3):520-7. PubMed ID: 19596480
[TBL] [Abstract][Full Text] [Related]
4. Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses.
Rudilla F; Fayolle C; Casares N; Durantez M; Arribillaga L; Lozano T; Villanueva L; Pio R; Sarobe P; Leclerc C; Prieto J; Lasarte JJ
Vaccine; 2012 Apr; 30(18):2848-58. PubMed ID: 22387222
[TBL] [Abstract][Full Text] [Related]
5. Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens.
Arribillaga L; Echeverria I; Belsue V; Gomez T; Lozano T; Casares N; Villanueva L; Domingos-Pereira S; Romero PJ; Nardelli-Haefliger D; Hervás-Stubbs S; Sarobe P; Rodriguez MJ; Carrascosa JL; Zürcher T; Lasarte JJ
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581060
[TBL] [Abstract][Full Text] [Related]
6. Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.
Stanek O; Linhartova I; Majlessi L; Leclerc C; Sebo P
Mol Biotechnol; 2012 Jul; 51(3):221-32. PubMed ID: 22006508
[TBL] [Abstract][Full Text] [Related]
7. Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin.
Mansilla C; Berraondo P; Durantez M; Martínez M; Casares N; Arribillaga L; Rudilla F; Fioravanti J; Lozano T; Villanueva L; Sarobe P; Borrás F; Leclerc C; Prieto J; Lasarte JJ
Int J Cancer; 2012 Aug; 131(3):641-51. PubMed ID: 21898393
[TBL] [Abstract][Full Text] [Related]
8. A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.
Park HJ; Jang GY; Kim YS; Park JH; Lee SE; Vo MC; Lee JJ; Han HD; Jung ID; Kang TH; Park YM
J Immunother Cancer; 2019 Feb; 7(1):60. PubMed ID: 30819254
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses.
Julier Z; de Titta A; Grimm AJ; Simeoni E; Swartz MA; Hubbell JA
Vaccine; 2016 May; 34(21):2453-2459. PubMed ID: 27016652
[TBL] [Abstract][Full Text] [Related]
10. Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.
Jing M; Wang J; Zhu S; Ao F; Wang L; Han T; Yue X; Zhu Y; Ye L; Liu S
Vaccine; 2016 Jan; 34(4):516-522. PubMed ID: 26686999
[TBL] [Abstract][Full Text] [Related]
11. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4.
Gondokaryono SP; Ushio H; Niyonsaba F; Hara M; Takenaka H; Jayawardana ST; Ikeda S; Okumura K; Ogawa H
J Leukoc Biol; 2007 Sep; 82(3):657-65. PubMed ID: 17575266
[TBL] [Abstract][Full Text] [Related]
12. Expression of a versatile DC-targeting fusion protein using an Adenovirus expression system.
Pillay S; Patterson S
Protein Expr Purif; 2012 Aug; 84(2):270-9. PubMed ID: 22728768
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
[TBL] [Abstract][Full Text] [Related]
14. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
[TBL] [Abstract][Full Text] [Related]
15. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine.
Julier Z; Martino MM; de Titta A; Jeanbart L; Hubbell JA
Sci Rep; 2015 Feb; 5():8569. PubMed ID: 25708982
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.
Doddapattar P; Jain M; Dhanesha N; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):500-508. PubMed ID: 29326316
[TBL] [Abstract][Full Text] [Related]
17. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
Schmitt S; Tahk S; Lohner A; Hänel G; Maiser A; Hauke M; Patel L; Rothe M; Josenhans C; Leonhardt H; Griffioen M; Deiser K; Fenn NC; Hopfner KP; Subklewe M
Front Immunol; 2020; 11():602802. PubMed ID: 33281829
[TBL] [Abstract][Full Text] [Related]
18. A two-component modular approach for enhancing T-cell activation utilizing a unique anti-FcgammaRI-streptavidin construct and microspheres coated with biotinylated-antigen.
Walsh MC; Banas JA; Mudzinski SP; Preissler MT; Graziano RF; Gosselin EJ
Biomol Eng; 2003 Jan; 20(1):21-33. PubMed ID: 12485681
[TBL] [Abstract][Full Text] [Related]
19. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
20. Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccines.
Park HJ; Qin H; Cha SC; Sharma R; Chung Y; Schluns KS; Neelapu SS; Overwijk WW; Hwu P; Kwak LW
Vaccine; 2011 Apr; 29(18):3476-82. PubMed ID: 21382485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
